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Early restoration of coronary antegrade flow limits the progression of myocardial necrosis and is thus expected to enhance the functional recovery of postischemic dysfunction of the myocardium in patients with AMI. [2] [3] [4] Previous studies have demonstrated that 'angiographic no-reflow' predicts poor left ventricular (LV) functional recovery and a higher risk of cardiac mortality during the early phase and long-term follow-up period in patients with AMI. 5, 6 However, the long-term prognosis after AMI remains unexplored in patients with angiographically successful reflow (TIMI (Thrombolysis in Myocardial Infarction) flow grade 3) after PCI.
Several recent studies have proved the clinical usefulness of echocardiography in predicting outcome in patients with congestive heart failure (CHF), 7 AMI 8 and CABG, 9 but its long-term prognostic value in patients with angiographically successful reflow after AMI is unknown. Thus, in the present study we analyzed the long-term prognostic value of echocardiography in a consecutive series of patients with complete coronary revascularization by primary PCI for an initial AMI. no more than 50% and TIMI flow grade 3 achieved after PCI; and (5) absence of apparent dissection or thrombosis that might restrict coronary flow. Patients excluded from the study were those with recurrent AMI (n=22), angiographic low-flow or no-reflow (TIMI ≤2, n=12), atrial fibrillation (n=3), valvular aortic stenosis (n=3), greater than grade 2/4 mitral regurgitation on echocardiography (n=5), chronic renal failure (n=5), and those who underwent emergency CABG (n=5). Patients who already had cardiac complications, including recurrent angina pectoris, recurrent myocardial infarction or cardiac rupture, or who died during their hospitalization period were also excluded from analysis of cardiac event-free survival. The Institutional Review Board of Yamaguchi University Hospital approved the study.
Coronary Angiography and Angioplasty
All angiograms were analyzed by 2 experienced observers and discrepancies were resolved by consensus. In all patients, the infarct-related artery was analyzed before and after PCI. Contrast flow through the epicardial vessel during angiography was graded according to the standard TIMI trial flow scale 0-3, 10 and retrograde collateral flow was scored according to the classification of Rentrop et al. 11 TIMI trial flow grade 3 was considered as angiographically successful reflow, and the presence of grade 2 or 3 collateral flow was considered significant. Multivessel disease was defined as ≥51% stenosis in either 2 or all 3 major epicardial coronary arteries. Left main coronary artery disease was defined as 40% diameter stenosis. By definition, all the patients in this study had TIMI 3 flow of the culprit vessel restored after PCI.
Echocardiography
Echocardiography was performed with the patients in the left lateral decubitus position. M-mode, 2-dimensional, pulsed Doppler and color Doppler echocardiographic studies were done with a phased array color Doppler echocardiographic unit (SSD-2200 or SSD-5500, ALOKA Co, Ltd, Tokyo, Japan) with a 2.5 MHz transducer.
Transmitral flow (TMF), pulmonary venous flow (PVF), LV end-diastolic and end-systolic diameters (LVDd and LVDs), LV ejection fraction (LVEF), and LV wall motion score index (LVWMSI) were analyzed before PCI and within 1 week of discharge after PCI when the patients were stable and the loading condition was controlled well with medication.
The LV wall was divided according to a 16-segment model 12 and for each segment, wall motion was scored as 1 (normal), 2 (hypokinetic), 3 (akinetic), or 4 (dyskinetic). The LVWMSI was obtained by adding the score of all examined segments and dividing it by the number of segments scored. Each echocardiographic examination was recorded on videotape and evaluated by 2 experienced observers. LVDd, LVDs, and LVEF were obtained by 2-dimensional guided M-mode echocardiography; LVDd ≥55 mm for males or ≥50 mm for females was considered as LV dilation.
According to the method of a previous study, 9 TMF was classified into 4 patterns: (1) normal pattern (N), characterized by E/A>1, normal deceleration time (180-220 ms), and the ratio of A-wave duration in TMF to that in PVF>1; (2) abnormal relaxation pattern (Ab), characterized by a prolonged deceleration time (≥220 ms), E/A≤1, and the ratio of A-wave duration in TMF to that in PVF>1; (3) pseudonormal pattern (PN), characterized by a shortened deceleration time (150-180 ms), 1<E/A<2, and the ratio of A-wave duration in TMF to that in PVF<1; and (4) restrictive pattern, characterized by a shortened deceleration time (≤150 ms), E/A ≥2, and the ratio of A-wave duration in TMF to that in PVF<1.
In-Hospital Clinical Course
Adjunctive medical therapy followed the standards of the coronary care unit. The following data were obtained: age, gender, coronary risk factors (eg, systemic hypertension, diabetes mellitus, hyperlipidemia, and smoking), serum creatine kinase concentrations, malignant arrhythmia (excluding reperfusion arrhythmia), ischemic time, and pump failure. Systemic hypertension was defined as systol- ic blood pressure >140 mmHg and/or diastolic blood pressure >90 mmHg; diabetes mellitus was defined as fasting blood sugar ≥140 mg/dl or blood sugar during a 75-g oral glucose tolerance test of ≥200 mg/dl; hyperlipidemia was defined as total cholesterol ≥220 mg/dl; malignant arrhythmia included sustained ventricular tachycardia, ventricular fibrillation, or high degree atrioventricular block; pump failure was defined as Forrester's subset class >2.
Analysis of Follow-up Data
Patients were seen every month at the outpatient clinic of Yamaguchi University Hospital and the follow-up data were assessed in February 2003, by which time all patients had completed the minimal follow-up period of 3 years (mean 46±20 months). Data were obtained from hospital charts and supplemented by records from the patient's general physicians. No patient was lost from follow-up. A cardiac event was defined as one of the following: (1) CHF; (2) recurrent AMI and/or a re-intervention procedure (eg, repeat PCI, or PCI for a new lesion) for unstable angina pectoris requiring hospitalization; or (3) CABG.
Statistical Analysis
Continuous data are expressed as mean ± SD. Baseline data were compared by means of the chi-square test for categorical variables and t-test for continuous variables. Cardiac event-free survival curves were constructed by Kaplan-Meier method. Statistical differences between curves were assessed with the log-rank test. The univariate Cox proportional hazards regression model was used for each separate variable for cardiac events as dependent variables. Finally, multiple logistic regression analyses, containing clinical, angiographic, and echocardiographic variables, were performed to assess the independent contribution of different variables for the risk of cardiac events during the follow-up period. A p-value <0.05 was considered significant. Statistical analysis was performed using StatView for Windows version 5.0 (SAS Institute Inc, 1998, Cary, NC, USA).
Results

Baseline Patient Characteristics
During the follow-up period (46±20 months), 2 patients (1.8%) were rehospitalized for nonfatal recurrent AMI, 11 (9.7%) for CHF and 13 (11.5%) for unstable angina pectoris, and 5 patients (4.4%) underwent CABG for coronary revascularization. The clinical and angiographic characteristics of the patients are shown in Table 1 . Compared with the patients in the no cardiac events group, those in the cardiac events group presented more often with hyperlipidemia, Forrester subset class >2, multivessel disease, left main coronary artery disease on admission, longer inhospital time, and shorter follow-up time period. Similar proportions of the 2 groups received angiotensin-converting enzyme inhibitors, -blockers, long-acting nitrates, and diuretics.
Cardiac Size and Function Based on Echocardiography
Although LVDd, LVDs, LVWMI, and LVEF on admission were similar in both groups, cases of relatively greater LVWMI or lower LVEF were found in the event group (Table 2) .
Independent Predictors of Cardiac Events
Congestive Heart Failure When only CHF was considered as the outcome event in the univariate analysis, the patients who rehospitalized for CHF presented with more frequent multivessel disease, Forrester subset class >2 on admission, PN, LV dilation, decreased LVEF (≤40%), and increased LVWMSI (≥1.5) on discharge (Table 3) . However, in the multivariate logical regression analysis, only PN (chi-square: 4.9, p<0.05), and LV dilation (chi-square: 7.5, p<0.01) at discharge were the most powerful predictors of CHF.
CHF-free survival curves showed a significantly poor prognosis in patients with PN and LV dilation at discharge than in patients with the N or Ab relaxation pattern ( Fig 1A) and no LV dilation (Fig 1B) .
Revascularization When repeat PCI, PCI for a new lesion, or CABG after PCI for recurrent AMI and unstable angina pectoris were considered as the outcome events in the univariate analysis, patients with one of the events presented more often with frequent hyperlipidemia, retrograde collateral flow grade 0 or 1, left main coronary artery disease, and multivessel disease (Table 4) . However, in the multivariate logical regression analysis, only multivessel Abbreviations see Table 2 .
Circulation Journal Vol.68, November 2004
disease (exponential of coefficient: 13.8, chi-square: 9.4, p=0.05) was the most powerful predictor of revascularization after PCI.
Total Cardiac Events
Patients with PN and LV dilation had a significantly higher incidence of cardiac events. The other univariate significant predictors of cardiac event-free survival were hyperlipidemia, collateral grade <2, left main coronary artery disease, multivessel disease, Forrester subset class >2 on admission, PN, LV dilation, and decreased LVEF (≤40%) based on echocardiography at discharge (Table 5) . Multivariate logical regression analysis also disclosed PN (chi-square: 6.7, p<0.01) and LV dilation (chi-square: 9.4, p<0.01) at discharge as independent predictors of total cardiac events.
Total cardiac event-free survival curves revealed a significantly worse prognosis in patients with PN and LV dilation at discharge than in those with the N or Ab relaxation pattern (Fig 2A) and no LV dilation (Fig 2B) .
Discussion
The present study has demonstrated, for the first time, the long-term prognostic value of echocardiography in patients with good coronary reflow (TIMI flow grade 3) after PCI for an initial AMI. The PN transmitral flow pattern and LV dilation at discharge could predict the occurrence of CHF and total cardiac events, but the other clinical, angiographic, or echocardiographic parameters could not.
Pathophysiology and Clinical Background of Patients With Angiographically Successful Reflow After PCI
The achievement of TIMI 3 flow in the infarct-related coronary artery is the primary goal of reperfusion therapy in patients with AMI, but patency of the vessel does not always mean myocardial perfusion in the related territory, as shown by studies using myocardial contrast echocardiography, 5 positron emission tomography, 13 radionuclide imaging, 14 or intravascular ultrasound. 15 In other words, angiographically successful reflow does not necessarily indicate adequate myocardial perfusion, because the ischemic episode can damage the coronary microvasculature and the flow to the infarcted myocardium may be reduced or absent (low-flow or no-reflow phenomenon). 16 The no-reflow phenomenon is associated with extensive myocardial necrosis and microcirculatory damage. [14] [15] [16] In this study, we showed that the combination of the PN transmitral flow pattern and LV dilation at discharge was associated with a higher incidence of cardiac events, even in patients in whom TIMI 3 flow in the infarct-related artery had been achieved after PCI. Therefore, echocardiography at discharge improves the identification of those patients who will have benefit from pharmacological adjunctive treatment to attenuate microvascular dysfunction and augment myocardial blood flow in the reperfused myocardium. [16] [17] [18] 
Predictors of Long-Term Clinical Outcome in Patients
With Angiographically Successful Reflow After PCI During the long-term follow-up period of this study no cardiac deaths occurred and the cumulative rates of CHF and nonfatal total cardiac events were 9.7% and 27%, respectively. In patients with angiographically successful reflow after PCI for an initial AMI our univariate analysis revealed that hyperlipidemia, collateral grade <2, left main coronary artery disease, multivessel disease, Forrester subset class >2 on admission, PN transmitral flow pattern, LV dilation, decreased LVEF (≤40%), and increased LVWMSI (≥1.5) at discharge were the risk factors of remote CHF and/or nonfatal total cardiac events.
Early reperfusion of the infarct-related artery results in greater myocardial salvage and better LV function; [19] [20] [21] however, it can be accompanied by reperfusion injury. 22, 23 When that occurs, the global LV systolic function does not improve immediately after reperfusion, instead it is deferred for a few days 24 or some months, 25, 26 a condition that is known as stunned myocardium. 27 The delayed improvement depends on several factors, such as the duration of ischemia before reperfusion, the degree of perfusion by means of collateral vessels, the severity of residual coronary stenosis after PCI, and the extent of the ischemic region. 24, 28 In this setting, LVEF and LVWMSI, which are strong predictors of an adverse outcome, cannot predict the outcome because of the stunned myocardium and/or the compensatory hyperkinesia of the undamaged myocardium. In the present study, the echocardiographic LVEF and LVWMSI showed a strong prognostic significance in the univariate analysis, but it was lost in the multivariate logical regression analysis, and instead LVDd (dilated) and impaired LV diastolic function (PN) at discharge were recognized as the most powerful predictors of a subsequent event. These results are consistent with previous observations [29] [30] [31] and therefore, the importance of LV dilation and LV diastolic dysfunction in predicting long-term cardiac event-free survival should be recognized, irrespective of acute therapy and angiographically successful reflow after PCI.
Relation Between LV Dilation, LV Diastolic Function and CHF
Progressive LV dilation after AMI, an important feature of LV remodeling, is strongly associated with adverse cardiovascular events and plays a particularly important role in the development of CHF. [32] [33] [34] Various factors have been considered influential in the development of LV remodeling, including infarct size, the perfusion status of the infarct-related artery, 33 the presence of asynergy 35 and increased wall stress. 32 During the longterm follow-up period of the present study, patients with LV diastolic dysfunction (PN transmitral flow pattern) and LV dilation developed CHF more often than those with N or Ab relaxation pattern without LV dilation. These observations suggest a link between CHF and LV diastolic dysfunction and/or LV dilation.
Predictors of Revascularization After PCI
In this study, echocardiographic variables were not selected as the predictors of revascularization after PCI. Other investigators have shown that chest pain and exercise stress testing following PCI are poor indicators of revascularization. 36, 37 Zellweger et al prospectively followed 356 patients who underwent coronary stenting and routine single-photon emission computed tomography (SPECT) imaging, and concluded that the extent and severity of ischemia as determined by SPECT was the best predictors of revascularization; 38 however, cost limits the clinical application of SPECT. Ito et al used intracoronary myocardial contrast echocardiography to simultaneously assess regional wall motion and myocardial perfusion in patients with AMI, and showed that the contrast defect in the risk area immediately after PCI was a predictor of poor functional recovery. 5 Therefore, when intravenous myocardial contrast echocardiography develops further in the future, it may become a valuable modality for predicting revascularization as well as poor functional recovery after PCI.
Study Limitations
(1) This was not a randomized study, but comprised consecutive patients enrolled in a long-term echocardiographic and clinical evaluation program.
(2) All of the cardiac event-free survivors continued as outpatients for at least 3 years after the onset of AMI. Thus, we obtained most of the data by reviewing hospital charts and by direct interview with the patients, which ensured the accuracy of the data and reduced any minimal bias produced by interhospital discrepancy.
(3) The relatively small study population and the different frequencies of hyperlipidemia, left main coronary artery disease, and multivessel disease between the 2 groups may limit the statistical power for detecting predictors of longterm survival or revascularization after AMI.
(4) We could not successfully analyze the effects of the drugs that patients had received before the onset of AMI.
(5) In cases of right ventricular infarction, transmitral flow may become weaker for predicting remote clinical outcome because of the reduced preload, although we did use the echocardiographic data obtained within 1 week of discharge after PCI when the patients were stable and the loading condition was controlled well with medication.
Conclusion
Poor LV diastolic function and LV dilation at discharge may be predictors of cardiac events in the long-term in patients with angiographically successful reflow after PCI for an initial AMI.
